Título: DIAGNOSTIC INTERVAL OF ORAL CANCER IN BRAZIL AND ASSOCIATED FACTORS
Nome do Apresentador: Lidiane de Jesus LISBOA
Categoria do Trabalho: Painel de pesquisa científica (PPC)
Área Temática: Oncologia
Resumo: Objective: To investigate the time and factors related to the diagnostic interval of oral cancer in Brazilian health services from 2000 to 2022.Study Design: Cross-sectional and hospital-based study, including 12,989 cases retrieved from the Hospital Cancer Registries of Brazil. Descriptive analyses were performed, and the negative binomial Poisson regression model was applied.Results: The majority of Brazilians with oral cancer were diagnosed at an advanced stage (70%), referred by the Unified Health System (SUS) (82%), and needed to travel from their municipality of residence to undergo treatment (63%). The median number of days between screening and the start of treatment was 63 days, with a range between 32 and 104 days. The data show that the referral source (p < 0.001) and the hospital region (p < 0.001) are important factors influencing the diagnostic interval, with individuals referred by SUS and treated in hospitals in the Midwest region (IRR 1.45) experiencing a longer interval than others.Conclusion: The healthcare interval in Brazil exceeds 60 days, which may impact treatment, prognosis, and quality of life of Brazilians.Funding Source: CNPq.
Autor 1: Lidiane de Jesus LISBOA
E-mail 1: [email protected]
Autor 2: Jean Carlos Zambrano CONTRERAS
E-mail 2: [email protected]
Autor 3 : Alessandra Laís Pinho Valente PIRES
E-mail 3: [email protected]
Autor 4: Adriana Mendonça da SILVA
E-mail 4: [email protected]
Autor 5: Ana Carla Barbosa de OLIVEIRA
E-mail 5: [email protected]
Autor 6: Jean Nunes dos Santos
E-mail 6: [email protected]
Autor 7: Valéria Souza FREITAS
E-mail 7: [email protected]
Para baixar o aplicativo, escolha abaixo: